Whole-exome sequencing reveals TopBP1 as a novel gene in idiopathic pulmonary arterial hypertension.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  2014-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/rccm.201310-1749OCPMID 24702692PMCID PMC4225850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• dbNSFP v3.0: A One‐Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice‐Site SNVs

  2016cited by this paper
• Role for DNA Damage Signaling in Pulmonary Arterial Hypertension

  2014cited by this paper
• Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.

  2014cited by this paper
• FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.

  2013cited by this paper
• dbNSFP v2.0: A Database of Human Non‐synonymous SNVs and Their Functional Predictions and Annotations

  2013cited by this paper
• A novel channelopathy in pulmonary arterial hypertension.

  2013cited by this paper
• In search of low-frequency and rare variants affecting complex traits

  2013cited by this paper
• Predicting Mendelian Disease-Causing Non-Synonymous Single Nucleotide Variants in Exome Sequencing Studies

  2013cited by this paper
• Hypoxia promotes cell proliferation by modulating E2F1 in chicken pulmonary arterial smooth muscle cells

  2013cited by this paper
• Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension

  2013cited by this paper
• A novel channelopathy in pulmonary arterial hypertension.

  2013cited by this paper
• New insights into the functions of histidine-rich glycoprotein.

  2013cited by this paper
• Genetics and genomics of pulmonary arterial hypertension.

  2013cited by this paper
• Genome-Wide Association Studies (GWAS) in Complex Diseases: Advantages and Limitations Enfermedades complejas y análisis genéticos por el método GWAS. Ventajas y limitaciones

  2012cited by this paper
• Genome-wide association studies (GWAS) in complex diseases: advantages and limitations.

  2012cited by this paper
• Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial Hypertension

  2012cited by this paper
• A comprehensive framework for prioritizing variants in exome sequencing studies of Mendelian diseases

  2012cited by this paper
• A Combined Functional Annotation Score for Non-Synonymous Variants

  2012cited by this paper
• Novel Role of ADAMTS-5 Protein in Proteoglycan Turnover and Lipoprotein Retention in Atherosclerosis*

  2012cited by this paper
• Loss of Adenomatous Poliposis Coli-&agr;3 Integrin Interaction Promotes Endothelial Apoptosis in Mice and Humans

  2012cited by this paper
• wANNOVAR: annotating genetic variants for personal genomes via the web

  2012cited by this paper
• Silencing of sodium-hydrogen exchanger 1 attenuates the proliferation, hypertrophy, and migration of pulmonary artery smooth muscle cells via E2F1.

  2011cited by this paper
• Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8.

  2011cited by this paper
• Exome sequencing as a tool for Mendelian disease gene discovery

  2011cited by this paper
• UniPathway: a resource for the exploration and annotation of metabolic pathways

  2011cited by this paper
• Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence

  2011cited by this paper
• Revisiting Mendelian disorders through exome sequencing

  2011cited by this paper
• What can exome sequencing do for you?

  2011cited by this paper
• Dpb11/TopBP1 plays distinct roles in DNA replication, checkpoint response and homologous recombination.

  2011cited by this paper
• Hydroxyurea (therapeutics and mechanism): metabolism, carbamoyl nitroso, nitroxyl, radicals, cell signaling and clinical applications.

  2011cited by this paper
• Regulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmonary Hypertension

  2011cited by this paper
• Pulmonary arterial hypertension: insights from genetic studies.

  2011cited by this paper
• The genetics of pulmonary arterial hypertension in the post-BMPR2 era

  2011cited by this paper
• ATR signalling: more than meeting at the fork.

  2011cited by this paper
• Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.

  2010cited by this paper
• GeneCards Version 3: the human gene integrator

  2010cited by this paper
• ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

  2010cited by this paper
• Mendelian bases of myopathies, cardiomyopathies, and neuromyopathies.

  2010cited by this paper
• TopBP1 functions with 53BP1 in the G1 DNA damage checkpoint

  2010cited by this paper
• TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study

  2010cited by this paper
• The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored

  2010cited by this paper
• Treslin collaborates with TopBP1 in triggering the initiation of DNA replication.

  2010cited by this paper
• Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

  2010cited by this paper
• Histidine‐rich glycoprotein functions cooperatively with cell surface heparan sulfate on phagocytes to promote necrotic cell uptake

  2010cited by this paper
• MutationTaster evaluates disease-causing potential of sequence alterations

  2010cited by this paper
• Identification of deleterious mutations within three human genomes.

  2009cited by this paper
• Genome-wide association studies of coronary artery disease and heart failure: where are we going?

  2009cited by this paper
• Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis.

  2009cited by this paper
• Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt–β-catenin and Wnt–RhoA–Rac1 pathways

  2009cited by this paper
• High affinity interaction between histidine-rich glycoprotein and the cell surface type ATP synthase on T-cells.

  2009cited by this paper
• Genetics and genomics of pulmonary arterial hypertension.

  2009cited by this paper
• Adaptive evolution of young gene duplicates in mammals.

  2009cited by this paper
• Smooth Muscle Protein 22&agr;–Mediated Patchy Deletion of Bmpr1a Impairs Cardiac Contractility but Protects Against Pulmonary Vascular Remodeling

  2008cited by this paper
• Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.

  2008cited by this paper
• Molecular pathogenesis of pulmonary arterial hypertension.

  2008cited by this paper
• The cancer paradigm of severe pulmonary arterial hypertension.

  2008cited by this paper
• Molecular pathogenesis of pulmonary arterial hypertension.

  2008cited by this paper
• Versican proteolysis mediates myocardial regression during outflow tract development

  2007cited by this paper
• Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension.

  2007cited by this paper
• Pathobiology of pulmonary hypertension.

  2007cited by this paper
• Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?

  2006cited by this paper
• TopBP1 activates the ATR-ATRIP complex.

  2006cited by this paper
• Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions.

  2006cited by this paper
• TOPping up ATR activity.

  2006cited by this paper
• Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways.

  2005cited by this paper
• Investigation of Second Genetic Hits at the BMPR2 Locus as a Modulator of Disease Progression in Familial Pulmonary Arterial Hypertension

  2005cited by this paper
• Characterization of the bone morphogenetic protein (BMP) system in human pulmonary arterial smooth muscle cells isolated from a sporadic case of primary pulmonary hypertension: roles of BMP type IB receptor (activin receptor-like kinase-6) in the mitotic action.

  2004cited by this paper
• MUSCLE: a multiple sequence alignment method with reduced time and space complexity

  2004cited by this paper
• Proteoglycans in atherosclerosis and restenosis: key roles for versican.

  2004cited by this paper
• Regulation of E2F1 by BRCT Domain-Containing Protein TopBP1

  2003cited by this paper
• Human Coronary Smooth Muscle Cells Internalize Versican-Modified LDL Through LDL Receptor–Related Protein and LDL Receptors

  2002cited by this paper
• Histone H2A variants H2AX and H2AZ.

  2002cited by this paper
• The pathobiology of pulmonary hypertension. Endothelium.

  2001cited by this paper
• Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.

  2000cited by this paper
• Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension

  2000cited by this paper
• Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.

  1998cited by this paper
• Primary pulmonary hypertension between inflammation and cancer.

  1998cited by this paper
• Prevalence of Elevated Histidine-Rich Glycoprotein in Patients with Thrombophilia - a Study of 695 Patients

  1994cited by this paper
• PRIMARY PULMONARY HYPERTENSION: A NATIONAL PROSPECTIVE STUDY

  1987cited by this paper

• Antiproliferative therapies in pulmonary arterial hypertension

  2025cites this paper
• Exploring the pathogenesis of pulmonary vascular disease

  2024cites this paper
• Novel insights into the potential applications of stem cells in pulmonary hypertension therapy

  2024cites this paper
• Hemodynamic and Clinical Profiles of Pulmonary Arterial Hypertension Patients with GDF2 and BMPR2 Variants

  2024cites this paper
• Wnt7a deficit is associated with dysfunctional angiogenesis in pulmonary arterial hypertension

  2023cites this paper
• Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension

  2023cites this paper
• The Role of Endothelial Cells in Pulmonary Hypertension: Old Concepts and New Science

  2023cites this paper
• Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan

  2022cites this paper
• Defining the Clinical Validity of Genes Reported to Cause Pulmonary Arterial Hypertension

  2022influential citation
• Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function

  2022cites this paper
• Endothelial Senescence: A New Age in Pulmonary Hypertension

  2022cites this paper
• Frataxin deficiency promotes endothelial senescence in pulmonary hypertension.

  2021cites this paper
• Genetic basis of pulmonary arterial hypertension: a prospective study from a highly inbred population

  2021cites this paper
• Comparative Transcriptional Analysis of Pulmonary Arterial Hypertension Associated With Three Different Diseases

  2021cites this paper
• Promising therapeutic approaches in pulmonary arterial hypertension.

  2021cites this paper
• Novel molecular insights and public omics data in pulmonary hypertension.

  2021cites this paper
• Novel TNIP2 and TRAF2 Variants Are Implicated in the Pathogenesis of Pulmonary Arterial Hypertension

  2021cites this paper
• Approaches to treat pulmonary arterial hypertension by targeting bmpr2 - from cell membrane to nucleus.

  2021cites this paper
• Pathobiology of Pulmonary Artery Hypertension: Role of lncRNAs.

  2020cites this paper
• ‘There and Back Again’—Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension

  2020cites this paper
• Peroxisome proliferator-activated receptor agonists and reversal of vascular degeneration through DNA repair, a step toward drug-induced regenerative medicine

  2020cites this paper
• Identification of the Novel Variants in Patients With Chronic Thromboembolic Pulmonary Hypertension

  2020cites this paper
• In Defense of the Nucleus: NUDT1 and Oxidative DNA Damage in Pulmonary Arterial Hypertension

  2020cites this paper
• Magnesium lithospermate B ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and its potential targets.

  2020cites this paper
• DNA Damage and Repair in Pulmonary Arterial Hypertension

  2020influential citation
• Customized Massive Parallel Sequencing Panel for Diagnosis of Pulmonary Arterial Hypertension

  2020cites this paper
• Endothelial Basement Membrane Components and Their Products, Matrikines: Active Drivers of Pulmonary Hypertension?

  2020cites this paper
• The DNA Damage Response and HIV-Associated Pulmonary Arterial Hypertension

  2020cites this paper
• Comprehensive identification of signaling pathways foridiopathic pulmonary arterial hypertension.

  2020cites this paper
• Genetic Predisposition to High-Altitude Pulmonary Edema

  2020cites this paper
• A Dynamic Scale-Free Network Particle Swarm Optimization for Extracting Features on Multi-Omics Data

  2019cites this paper
• Genetics and genomics of pulmonary arterial hypertension

  2019cites this paper
• A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension

  2019cites this paper
• PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis.

  2019cites this paper
• The Search for Disease-Modifying Therapies in Pulmonary Hypertension

  2019cites this paper
• Pulmoner hipertansiyonlu hastalarda comet analizi ile değerlendirilen artmış DNA hasarı

  2019cites this paper
• TUG1 Regulates Pulmonary Arterial Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension.

  2019cites this paper
• Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure

  2019cites this paper
• Constraint on Rare Protein-Coding Variation: Pathogenicity Prediction and Phenotypic Discovery

  2018cites this paper
• A mini review about Tip60 functional mechanism: A potential therapeutic target in Cardiovascular Disease

  2018cites this paper
• Three-dimensional spatial analysis of missense variants in RTEL1 identifies pathogenic variants in patients with Familial Interstitial Pneumonia

  2018cites this paper
• Bone morphogenetic protein signaling is required for RAD51-mediated maintenance of genome integrity in vascular endothelial cells

  2018cites this paper
• Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension

  2018cites this paper
• Genetic analyses in a cohort of 191 pulmonary arterial hypertension patients

  2018cites this paper
• Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk‐associated and related genes

  2018cites this paper
• DNA damage‐dependent mechanisms of ageing and disease in the macro‐ and microvasculature

  2017cites this paper
• The cancer theory of pulmonary arterial hypertension

  2017cites this paper
• Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing

  2017cites this paper
• Genetics of Pulmonary Arterial Hypertension

  2017cites this paper
• Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension.

  2017cites this paper
• Using omics approaches to understand pulmonary diseases

  2017influential citation
• A systematic review of genetic mutations in pulmonary arterial hypertension

  2017cites this paper
• Genomic stability of pulmonary artery endothelial colony-forming cells in culture

  2017cites this paper
• Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.

  2017cites this paper
• Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series)

  2017cites this paper
• Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension.

  2017cites this paper
• Reduced carboxylesterase 1 is associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension.

  2017cites this paper
• Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.

  2016cites this paper
• Versican Accumulates in Vascular Lesions in Pulmonary Arterial Hypertension

  2016cites this paper
• Identification of genetic defects in pulmonary arterial hypertension by a new gene panel diagnostic tool.

  2016cites this paper
• Translationally Controlled Tumour Protein as a Novel Therapeutic Target in Pulmonary Arterial Hypertension

  2016cites this paper
• Genetic Insights into Pulmonary Arterial Hypertension. Application of Whole-Exome Sequencing to the Study of Pathogenic Mechanisms.

  2016cites this paper
• DNA Damage and Pulmonary Hypertension

  2016cites this paper
• Genetics and its Associated Pathways of Pulmonary Arterial Hypertension

  2016cites this paper
• Novel approaches to pulmonary arterial hypertension drug discovery

  2016cites this paper
• Update in Pulmonary Vascular Disease 2015.

  2016cites this paper
• Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension

  2016cites this paper
• Genetic Insights into Pulmonary Arterial Hypertension Application of Whole-Exome Sequencing to the Study of Pathogenic Mechanisms

  2016cites this paper
• Complex genetics of pulmonary diseases: lessons from genome-wide association studies and next-generation sequencing.

  2016cites this paper
• Molecular pathogenesis and current pathology of pulmonary hypertension

  2016cites this paper
• Increased Pyruvate Dehydrogenase Kinase 4 Expression in Lung Pericytes Is Associated with Reduced Endothelial-Pericyte Interactions and Small Vessel Loss in Pulmonary Arterial Hypertension.

  2016cites this paper
• Exome Sequencing Analysis in Severe, Early-Onset Chronic Obstructive Pulmonary Disease.

  2016cites this paper
• PULMONARY, SLEEP, AND CRITICAL CARE UPDATE Update in Pulmonary Vascular Diseases 2014

  2015cites this paper
• Update in Pulmonary Vascular Diseases 2014.

  2015cites this paper
• Increased Mutagen Sensitivity and DNA Damage in Pulmonary Arterial Hypertension.

  2015cites this paper
• Sex-dependent influence of endogenous estrogen in pulmonary hypertension.

  2014cites this paper